(-)-Syringaresinol inhibits proliferation of human promyelocytic HL-60 leukemia cells via G1 arrest and apoptosis

International Immunopharmacology

Volumn 8, Issue 7, 2008, Pages 967-973

  Park, Bo Young ^a   Oh, Sei Ryang ^a   Ahn, Kyung Seop ^a   Kwon, Ok Kyong ^a   Lee, Hyeong Kyu ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

( ) syringaresinol; Apoptosis; Bax; Bcl 2; Caspase 3; Cdk; Cdki

Indexed keywords

CASPASE 3; CASPASE 9; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYTOCHROME C; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; SYRINGARESINOL;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CYTOCHROMES C; FURANS; G1 PHASE; HL-60 CELLS; HUMANS; LIGNANS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 43649097274     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.02.012     Document Type: Article

References (20)

1. Buolamwini J.K. Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6 (2000) 379-392
2. McDonald E.R., and EI-Deiry W.S. Cell cycle control as a basis for cancer drug development. Int J Oncol 16 (2000) 871-886
3. 1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8 (2001) 1487-1503
4. Deigner H.P., and Kinscherf R. Modulating apoptosis: current applications and prospects for future drgu development. Curr Med Chem 6 (1999) 399-414
5. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9 (2002) 459-470
6. Korsmeyer S.J. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res 8 (1999) 2666-2674
7. Cho J.Y., Kim A.R., Yoo E.S., Baik K.U., and Park M.H. Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-a and nitric oxide production, and lymphocyte proliferation. J Pharm Pharmacol 51 (1999) 1267-1273
8. Hausott B., Greger H., and Marian B. Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells. J Cancer Res Clin Oncol 129 (2003) 569-576
9. Matsumoto T., Hosono-Nishiyama K., and Yamada H. Antiproliferative and apoptotic effects of butyrolactone lignans from Arctium lappa on leukemic cells. Planta Med 72 (2006) 276-278
10. Nikaido T., Ohmoto T., Kinoshita T., Sankawa U., Nishibe S., and Hisada S. Inhibition of cyclic AMP phosphodiesterase by lignans. Chem Pharm Bull 29 (1981) 3586-3592
11. Jung H.J., Park H.J., Kim R.G., Shin K.M., Ha J.H., Choi J.W., et al. In vivo anti-inflammatory and antinociceptive effects of liriodendrin isolated from the stem bark of Acanthopanax senticousus. Planta Med 69 (2003) 610-616
12. Ma J., Jones S.H., Marshall R., Wu X., and Hecht S.M. DNA topoisomerase I inhibitors from Rinorea anguifera. Bioorg Med Chem Lett 15 (2005) 813-816
13. Miyazawa M., Utsunomiya H., Inada K.I., Yamada T., Okuno Y., Tanaka H., et al. Inhibition of Helicobacter pylori motility by (+)-syringaresinol from unripe Japanese Apricot. Biol Pharm Bull 29 (2006) 172-173
14. Fujikawa T., Yamaguchi A., Morita I., Takeda H., and Nishibe S. Protective effects of Acanthopanax senticosus harms from Hokkaido and its components on gastric ulcer in restrained cold water stressed rat. Biol Pharm Bull 19 (1996) 1227-1230
15. Nishibe S., Kinoshita H., Takeda H., and Okano G. Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chem Pharm Bull 38 (1990) 1763-1765
16. Benyahia S., Benayache S., Benayache F., Quintana J., Lopez M., Leon F., et al. Isolation from Eucalyptus occidentalis and identification of a new kaempferol derivative that induces apoptosis in human myeloid leukemia cells. J Nat Prod 67 (2004) 527-531
17. Collins K., Jacks T., and Pavletich N.P. The cell cycle and cancer. Proc Natl Acad Sci USA 94 (1997) 2776-2778
18. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., and Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, CIP/WAF1/CIP1, expression in the absence of p53. Oncogene 9 (1994) 3397-3406
19. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33 (2000) 261-274
20. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132